Healthcare systems globally are taking steps to enhance quality and safety measures in outpatient settings. This comes as a direct response to the increase in medical procedures historically only handled in hospitals being transitioned to ambulatory facilities.
The Centers for Medicare and Medicaid Services (CMS) recently phased out their inpatient-only list under the 2026 hospital outpatient payment rule. This list traditionally restrained Medicare reimbursement for certain procedures only when performed in hospital inpatient settings. The updated regulations eliminate 285 procedures from the list, while adding 289 to the Ambulatory Surgical Center (ASC) covered procedures list. This indicates a significant surge in transferring surgical care to outpatient settings.
Clinical heads argue for the need for a more robust quality and safety monitoring framework across ambulatory networks. Current transformations demand rigorous patient evaluation before the delivery of care and necessity for comprehensive and refined protocols for patient selection. The balance between ambulatory expansion and appropriate site-of-care determinations is vital, ensuring that patients can safely receive care in these new settings.
Concurrently, healthcare leaders are bolstering staff training programs across ambulatory networks, priming frontline teams to handle the incoming wave of services transitioning to outpatient settings. Furthermore, robust patient education is becoming increasingly essential, as patients will need clear guidance on post-procedure recovery and the management of potential complications. Leveraging modern data infrastructure and emerging technologies plays a pivotal role in supporting effective care coordination across multiple settings.
Implementing comprehensive quality and safety programs across ambulatory sites can address the larger void in regulatory oversight, presenting opportunities not only to standardize safety and quality standards but also to build internal governance structures in the face of inconsistent regulatory landscapes.